Original Research
Published on 03 Nov 2023
Impact of China’s National Centralized Drug Procurement Policy on pharmaceutical enterprises’ financial performance: a quasi-natural experimental study
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2023.1227102
- 9,592 views
- 12 citations
